Literature DB >> 33529353

Pleiotrophin interacts with glycosaminoglycans in a highly flexible and adaptable manner.

Eathen Ryan1, Di Shen1, Xu Wang1.   

Abstract

Pleiotrophin (PTN) is a potent mitogenic cytokine whose activities are controlled by its interactions with glycosaminoglycan (GAG). We examined the specificity of PTN for several types of GAG oligosaccharides. Our data indicate that the interaction of PTN with GAGs is dependent on the sulfation density of GAGs. Surprisingly, an acidic peptide also had similar interactions with PTN as GAGs. This shows that the interaction of PTN with anionic polymers is flexible and adaptable and that the charge density is the main determinant of the interaction. In addition, we show that PTN can compensate for the loss of its termini in interactions with heparin oligosaccharides, allowing it to maintain its affinity for GAGs in the absence of the termini. Taken together, these data provide valuable insight into the interactions of PTN with its proteoglycan receptors.
© 2021 Federation of European Biochemical Societies.

Entities:  

Keywords:  NMR; PTPRZ; glycosaminoglycan; pleiotrophin

Year:  2021        PMID: 33529353     DOI: 10.1002/1873-3468.14052

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Pleiotrophin Interaction with Synthetic Glycosaminoglycan Mimetics.

Authors:  Jonathan R Miles; Xu Wang; Jose L de Paz; Pedro M Nieto
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-19

Review 2.  Molecular Mechanisms and Clinical Challenges of Glioma Invasion.

Authors:  Tomoya Oishi; Shinichiro Koizumi; Kazuhiko Kurozumi
Journal:  Brain Sci       Date:  2022-02-20

3.  Interactions of Pleiotrophin with a Structurally Defined Heparin Hexasaccharide.

Authors:  Eathen O Ryan; Zhoumai Jiang; Hoa Nguyen; Xu Wang
Journal:  Biomolecules       Date:  2021-12-30

4.  The Interaction between Chondroitin Sulfate and Dermatan Sulfate Tetrasaccharides and Pleiotrophin.

Authors:  María Jose García-Jiménez; Myriam Torres-Rico; José L de Paz; Pedro M Nieto
Journal:  Int J Mol Sci       Date:  2022-03-11       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.